Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials (Q34390550)

1 August 2017

0 references

Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Haohai Huang

1

1 reference

1 August 2017

Lijun Song

series ordinal

2

1 reference

1 August 2017

Wenchang Zhao

series ordinal

3

1 reference

1 August 2017

publication date

8 December 2013

1 reference

Archives of Gynecology and Obstetrics

1 August 2017

published in

1 reference

1 August 2017

volume

289

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

1225-1234

1 reference

The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Adherent biofilms in bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

The application of biofilm science to the study and control of chronic bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Use of Lactobacillus to prevent infection by pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Disruption of urogenital biofilms by lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Long-term vaginal administration ofLactobacillus rhamnosusas a complementary approach to management of bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Targeting the vaginal microbiota with probiotics as a means to counteract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Probiotic Lactobacilli for urogenital health in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Probiotics for the treatment of women with bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Probiotic strategies for the treatment and prevention of bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3117-0

10.1007/S00404-013-3117-0

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2bi67fnjtffyzpfc5mgb3illgi

mapped directly with Wikidata item

30 July 2022

based on heuristic

Dimensions Publication ID

1007302168

0 references

Fatcat ID

release_2bi67fnjtffyzpfc5mgb3illgi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2bi67fnjtffyzpfc5mgb3illgi

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/2bi67fnjtffyzpfc5mgb3illgi

1 reference